As of 2024-12-11, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (14.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -2229.9%.
The range of the Relative Valuation is (6.45) - (23.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 18.3x | 11.6x |
| Forward P/E multiples | 5.1x - 18.7x | 11.9x |
| Fair Price | (6.45) - (23.16) | (14.90) |
| Upside | -1022.5% - -3410.2% | -2229.9% |
| Date | P/E |